Clinical Trials Sponsored by EPI-Q

Total 2931 results

EPI-Q

Completed

Validation of a Patient Decision Aid for Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
EPI-Q

Withdrawn

A Prospective, Observational Study of COPD Patients in U.S. Hospitals

Chronic Obstructive Pulmonary Disease
Q Therapeutics, Inc.

Recruiting

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

Transverse Myelitis

United States
Q Therapeutics, Inc.

Not yet recruiting

Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis
Xeltis
Q-Med Scandinavia, Inc.

Completed

Safety and Performance of a Vascular Patch in Pediatric Patients Undergoing Bidirectional Cava-pulmonary Anastomosis (XEL-CR-06)

Heart Defects, Congenital

Russian Federation
Kancera AB
LINK Medical Research AB; CRST Oy; Q&Q Labs AB

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145

Ovarian Cancer

Finland
Region Skane
Q-Pharma; Octean

Completed

Impact of Antioxidant Treatment on DNA Fragmentation Index (Androferti)

Male Infertility
Laboratorios Liomont
EPIC Research CRO; ILS Clinical Research; Q Square Solutions

Completed

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Influenza, Human

Mexico
Hi-Q Marine Biotech International, Ltd.

Recruiting

Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma

China
Hi-Q Marine Biotech International, Ltd.

Recruiting

A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck

Squamous Cell Carcinomas of the Head and Neck

Taiwan
Hi-Q Marine Biotech International, Ltd.

Withdrawn

To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC

NSCLC Stage IV | NSCLC, Stage III

Taiwan
Lument AB
Q Clinical Research AB

Completed

A Healthy Volunteer Trial Investigating MR-enterography Image Quality of Lumentin® 44

Healthy

Sweden
South Shore Hospital
Q-Med Scandinavia, Inc.

Terminated

Minimally Invasive Closure of Umbilical Hernias (MIC)

Umbilical Hernia

United States
Lallemand Health Solutions
MedQualis; Q & T Research

Completed

Efficacy of 2 Probiotics During Nicotine Replacement Therapy on Withdrawal Symptoms Associated With Smoking Cessation

Smoking Cessation

Canada
Medicines for Malaria Venture
Q-Pharm Pty Limited

Terminated

MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants

Malaria, Falciparum

Australia
University of California, Los Angeles
High Q Foundation

Completed

Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease (HD)

Huntington's Disease

United States
Medicis Global Service Corporation
Q-Med Scandinavia, Inc.

Completed

Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds

Nasolabial Folds

United States
Medicis Global Service Corporation
Q-Med Scandinavia, Inc.

Completed

Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose

Nasolabial Folds

United States
Taipei Medical University WanFang Hospital
Hi-Q Marine Biotech International, Ltd.

Unknown

Supplementation of Brown Seaweed on Insulin Resistance of NAFLD Patients With Pre- or Type 2-Diabetes

Type II Diabetes

Taiwan
João Luiz Q. Durigan
Catholic University of Brasília

Completed

Effects of Training Based on the Pilates Method on the Blood Pressure of Hypertensive Women

Hypertension

Brazil
EPI-PHARE

Completed

Routine Surgical Procedures During COVID-19 Pandemic: a French Nationwide Cohort Study

Cataract | Surgery | Knee Arthroplasty | COVID-19 Pandemic | Hip Arthroplasty | Pacemaker | Coronary Stent

France
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan; Q-Pharm Pty...

Completed

Safety and Blood Level Study of Unit Dose Budesonide (UDB P101)

Asthma

Australia
Gilead Sciences
Parexel; IQVIA RDS (Shanghai) Co., Ltd.; Medidata Solutions; Q Squared Solutions...

Active, not recruiting

Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments

Metastatic Triple-negative Breast Cancer

China
Medicines for Malaria Venture
Q-Pharm Pty Limited; Trident Clinical Research Pty Ltd; Queensland Institute...

Completed

A Pilot Study to Test Activity of Antimalarial Drugs Against an Induced Malaria Infection in Healthy Volunteers

Healthy | Non-smokers

Australia
Charite University, Berlin, Germany
Prof. Dr. Stefan M. Gold; Prof. Dr. Soyoung Q Park; Dr. Ulrike Grittner; Motognosis...

Recruiting

Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation (MOTIVADE)

Depressive Disorder, Major

Germany
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265 (OZ/DSMCombo)

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; Queensland Institute...

Terminated

A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection (DSMOZ-2)

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

SJ733 Induced Blood Stage Malaria Challenge Study (SJ733IBSMCS)

Plasmodium Falciparum Malaria

Australia
Fundación EPIC

Recruiting

Essential Pro PMCF Study ( rEPIC04E ) (rEPIC04E)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

ANGiographic Evaluation of Left Main Coronary Artery INtErvention (ANGELINE)

Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery Stenosis

Spain
Fundación EPIC

Active, not recruiting

Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR (iLITRO)

Coronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, Coronary

Spain
Fundación EPIC

Completed

NAVISCORE PMCF Study ( rEPIC04F ) (rEPIC04F)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación EPIC

Completed

Laser-excimer Versus High-pressure Dilation to Treat Under-expansion of the Stent (LASER EXPAND)

Cardiovascular Diseases | Arterial Disease

Spain
Fundación EPIC

Completed

Xperience Pro PMCF Study (rEPIC04A)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Active, not recruiting

Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile (Monitor- ACS)

Heart Diseases | Atrial Fibrillation | Arrhythmias, Cardiac | Syncope | Tachycardia

Spain
Fundación EPIC

Active, not recruiting

Registry of Coronary Lithotripsy in Spain. (REPLICA)

Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Arteriosclerosis | Arterial Occlusive Diseases

Spain
Fundación EPIC

Active, not recruiting

PRospective Evaluation Complementing Investigation With Acurate Neo Device (PRECISA)

Aortic Stenosis

Spain
EPS Corporation

Completed

Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases (ATOM)

Liver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer

Japan
Fundación EPIC

Recruiting

PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients (PARIS)

Coronary Artery Disease

Spain
Fundación EPIC

Not yet recruiting

Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)

Coronary Disease
Fundación EPIC

Recruiting

Comparison Between Optical Coherence Tomography and Intravascular Ultrasound for Intermediate Left Main Coronary Artery Lesions (EMPERATRIZ)

Coronary Disease

Spain
Fundación EPIC

Recruiting

Sequent Extended Study (rEpic06)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación EPIC

Recruiting

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation (FAST TRACK)

Aortic Valve Stenosis | Aortic Valve Disease | Heart Valve Diseases

Spain
Fundación EPIC

Recruiting

Coroflex® ISAR NEO PMCF Study (rEPIC07)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

SUPRAFLEX CRUZ PMCF Study ( rEpic05 ) (Multiflex)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

Navitian PMCF Study ( rEPIC04C ) (rEPIC04C)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain, Portugal
Fundación EPIC

Not yet recruiting

Double Rewire Versus Double Kissing Crush Stenting Technique in Left Main Bifurcation Lesions (DR vs DK crush)

Coronary Artery Disease

Clinical Trials Sponsored by EPI-Q

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations